Ani Pharmaceuticals (ANIP) EBT Margin Growth (5y) (2016 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EBT Margin Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,137.00 |
| Mar 31, 2026 | 1,675.00 |
| Dec 31, 2025 | 1,687.00 |
| Sep 30, 2025 | 1,472.00 |
| Jun 30, 2025 | 3,345.00 |
| Mar 31, 2025 | 3,003.00 |
| Dec 31, 2024 | 873.00 |
| Sep 30, 2024 | -2,903.00 |
| Jun 30, 2024 | -1,257.00 |
| Mar 31, 2024 | 1,670.00 |
| Dec 31, 2023 | -1,213.00 |
| Sep 30, 2023 | -382.00 |
| Jun 30, 2023 | -291.00 |
| Mar 31, 2023 | -405.00 |
| Dec 31, 2022 | -1,528.00 |
| Sep 30, 2022 | -2,782.00 |
| Jun 30, 2022 | -3,430.00 |
| Mar 31, 2022 | -4,474.00 |
| Dec 31, 2021 | -4,644.00 |
| Sep 30, 2021 | -2,679.00 |